At Copptech, we firmly believe that the future is based on innovation and strategic collaborations alongside our partners. It is with great enthusiasm that we highlight our alliance with LP Chile, a bold step towards a more innovative tomorrow and connected with our community.
A Commitment to Innovation
Copptech has always been at the forefront of antimicrobial technology, working tirelessly to develop solutions that not only address current challenges but also anticipate future needs. Our mission is about generating a real and positive impact on the lives of people and the communities we serve.
LP Chile: A Bridge to the Community
The collaboration with LP Chile is essential in our mission to strengthen ties with our community. Recognized for their commitment to excellence and quality, LP Chile helps us expand our presence and understand more deeply the needs of our consumers. This alliance not only offers us the possibility to spread our technology and expertise but also to enrich ourselves with the lessons learned in the face of the challenges and opportunities that arise looking towards the future.
Greater Visibility and Approach
Our collaboration with LP Chile has been a catalyst for a notable increase in our visibility in the main media of Chile, significantly improving our market presence. This greater media recognition has solidified our competitive position, providing us with a deeper understanding of the needs of both our current clients and future partners. This extensive exposure has given us a unique opportunity to promote our commitment to innovation and demonstrate the added value of our solutions in people’s daily lives, especially through our advanced antimicrobial technology.
Collaborative Innovation
The collaboration with LP Chile enhances our strengths, merging knowledge and resources to foster innovation in the industry. This partnership allows us to work in a coordinated manner on the development of innovative applications for our antimicrobial technology, optimizing them to meet the demands of various sectors and specific requirements. This synergy not only speeds up the innovation process but also ensures that our solutions are more relevant and accessible to a wide range of users.
Looking to the Future
Looking forward, we are excited about the endless possibilities that this strategic alliance with LP Chile opens for us and our community. We are committed to continuing to work together to explore new frontiers, overcome challenges, and create a future full of significant innovations that benefit everyone.
Conclusion
The strategic alliance between Copptech and LP Chile is a testament to our commitment not only to innovation but also to our community. Together, we are laying the foundations for a future where technology and collaboration come together to create a better and more connected world. With greater visibility in the Chilean media, we are closer than ever to our customers and partners, leading the way towards a future full of innovation.
“The antimicrobial technology that aims to protect the world from microbes”
On November 22nd, in the Work Café Santander program on Radio Infinita, there was a revealing interview between Bárbara Silberberg, co-founder of Copptech, and presenter Soledad Onetto. Throughout this dialogue, key aspects of the company and its innovative technology were explored.
The conversation began with Copptech’s history, from its origins focused on copper formulations to its expansion to other ingredients, demonstrating its continuous evolution and adaptability. This evolution aligns with its venture into the United Kingdom, supported by a strategic partnership with the British government to establish its headquarters there.
During the conversation, Silberberg emphasized Copptech’s commitment to providing protection and well-being to everyone. She remarked: “This is a technology with a powerful benefit that can change the world.” This statement reflected the company’s ambition and conviction in the global impact of its technology.
The essence of Copptech is highlighted by innovation, science, creativity, and flexibility, characteristics ingrained in the DNA of its people, challenging conventional thinking every day. This approach is reflected in the variety of applications and formulations of Copptech across various industries, such as textiles, industrial, plastics, and more. This diversity is made possible through Copptech’s relationships with partners, prioritizing collaboration in the constant pursuit of innovation.
The interview at the Work Café Santander on Radio Infinita not only highlighted Copptech’s cutting-edge technology but also provided a comprehensive view of its history, principles, strategic objectives, and commitment to a positive impact on people. This interview introduced a company committed to innovation and improving the world through its technology.
About Copptech™ Antimicrobial Technology: Copptech™ Antimicrobial Technology is a rapidly growing biotechnology company recognized by Diario Financiero as one of Chile’s 10 most valuable intellectual property brands. Its patented technology uses copper, zinc, and other natural elements to inhibit growth and eliminate up to 99.9% of bacteria and mold, reducing odors, helping food stay fresh longer, and increasing the lifespan of a wide range of materials. Copptech™ Antimicrobial Technology is present in products from Kimba, LP Chile, Arauco, as well as in products from its innovative US-based partner, Purra Performance.
Founded in Santiago, Chile, the company is headquartered in London, United Kingdom, serving clients in Latin America, the United States, and Europe.
You can watch the full interview here
Chile is classified as one of the best countries to invest in Latin America.
Hand in hand with the Chilean firm Copptech, the English executive and investor will participate in Unicorn Kingdom, an initiative that will take place in Chile next week and aims to encourage new national startups to venture into the European market.
by MARÍA JESÚS COLOMA
“Unicorn Kingdom” is a global campaign by the British government aimed at encouraging international technology companies and venture capital funds to do business in the United Kingdom. On November 14, it will land in Chile. Here, local startups will be able to present their projects to a group of British investors, as well as Chilean investors and national companies already established in that European country. One of the participants in the event is Hugh Minnock, investment director of the British fund Foresight Group, who has been able to get to know the Chilean ecosystem after being part of Copptech’s Series B, where they raised US$ 5.5 million in 2021 (see box). Prior to his participation in “Unicorn Kingdom,” Minnock spoke with “El Mercurio” about the potential he sees in the country and the perception of our ecosystem abroad.
– How has your experience been investing in a Chilean company? “Each company we invest in has unique properties and potential. I cannot speak for all Chilean companies, but Copptech certainly has a value proposition that we found attractive, along with their professionalism. It takes commitment along with a community of co-investors who have helped us understand the opportunities available to Copptech both in the United Kingdom and Chile. That said, as with all startups, there are risks, but at Foresight, we offer more than just investment; we partner with our portfolio to share operational knowledge, guidance, and connections, helping the companies we support achieve their business ambitions.
– Do you think Chile is an attractive market for the United Kingdom? “The event ‘Unicorn Kingdom’ and ‘GREAT’ focus on encouraging promising entrepreneurs and innovators to consider the United Kingdom as a place to grow and succeed. The commitment of the United Kingdom government to Chile demonstrates their belief that it is a market that fosters a significant growth spirit both in Latin America and the United Kingdom.”
BÁRBARA SILBERGER OF COPPTECH: “ESPECIALLY USEFUL TO HAVE A FUND WITH GLOBAL EXPERIENCE”
Copptech, a Chilean firm that offers antibacterial and antiviral technology based on copper, currently has a presence in Latin America, the United States, Asia, and recently opened a new office in London and an R&D center in Manchester. In their global perspective, this “allows them to be at the forefront of challenges in all markets and geographies,” says co-founder Bárbara Silberger, who will also participate in “Unicorn Kingdom.” For Silberger, the contribution of investors is key to the company’s growth, but she adds that having the presence of a fund like Foresight also allows them to open new and more doors. “It is especially useful to have a fund with global experience and a firm presence in the United Kingdom, as it can support our efforts as we move beyond Chile and Latin America towards the United States and Europe.” Copptech, founded in Chile in 2014, initially focused on researching and developing its products until 2016 when they had their first connection with the United Kingdom. On that occasion, they conducted clinical trials for the National Health Service (NHS), which revealed that through the developed technology, it could reduce the days by 38%.
Foresight VCTs invest £5 million in antimicrobial technology developer Copptech
Foresight Group, one of the most relevant Private Equity groups in the UK. has become our new Copptech partner. Their Senior Investment Manager, Hugh Minnock, has recently joined Copptech’s board of directors.
Thanks for joining us in this project with your experience and enthusiasm!
You can learn more about the investment about Fresight Group Investment at the IFA Magazine Article.
We leave you with some words Hugh gave us at his visit to Santiago, Chile.